Show simple item record

dc.contributor.authorSharif, Faisal
dc.contributor.authorHynes, Sean O
dc.contributor.authorCooney, Ronan
dc.contributor.authorHoward, Linda
dc.contributor.authorMcMahon, Jill
dc.contributor.authorDaly, Kieran
dc.contributor.authorCrowley, James
dc.contributor.authorBarry, Frank
dc.contributor.authorO'Brien, Timothy
dc.date.accessioned2018-09-20T16:24:29Z
dc.date.available2018-09-20T16:24:29Z
dc.date.issued2008-10-01
dc.identifier.citationSharif, Faisal; Hynes, Sean O; Cooney, Ronan; Howard, Linda; McMahon, Jill; Daly, Kieran; Crowley, James; Barry, Frank; O'Brien, Timothy (2008). Gene-eluting stents: adenovirus-mediated delivery of enos to the blood vessel wall accelerates re-endothelialization and inhibits restenosis. Molecular Therapy 16 (10), 1674-1680
dc.identifier.issn1525-0016
dc.identifier.urihttp://hdl.handle.net/10379/13878
dc.description.abstractDrug-eluting stents for coronary artery disease results in inhibition of smooth muscle cell (SMC) and endothelial cells which may increase the risk of stent thrombosis. In this study, we attempted to enhance re-endothelialization of deployed stents while simultaneously inhibiting intimal hyperplasia by overexpression of endothelial nitric oxide synthase (eNOS) delivery in the vasculature using an adenovirus gene-eluting stent. Re-endothelialization was significantly greater in vessels obtained from normocholesterolemic animals at day 14 (85.34% +/- 7.38 versus 62.66% +/- 10.49; P < 0.05) and day 28 (91.1% +/- 10 versus 63.1% +/- 22; P < 0.05) and hypercholesterolemic animals (96.97% +/- 3.2 versus 28.33% +/- 38.76; P < 0.05) at day 28 with AdeNOS-eluting stents. At day 28, there was a significant increase in the lumen size [AdeNOS 2.73 mm(2) +/- 1.18, Ad beta Gal 0.98 mm(2) +/- 0.98, phosphorylcholine (PC) 1.87 mm(2) +/- 1.18; P < 0.05], and a significant reduction in neointimal formation (AdeNOS 2.32 mm(2) +/- 1.13, Ad beta Gal 3.73 mm(2) +/- 0.95, PC 3.2 mm(2) +/- 0.94; P < 0.05), and percent restenosis (AdeNOS 45.23 +/- 20.81, Ad beta Gal 79.6 +/- 20.31, PC 70.16 +/- 22.2; P < 0.05) in AdeNOS-stented vessels in comparison with controls from hypercholesterolemic animals, assessed by morphometry and quantitative coronary angiography (AdeNOS 15.95% +/- 7.63, Ad beta Gal 56.9% +/- 38.6, PC 58 +/- 34.6; P < 0.05). Stent-based delivery of AdeNOS results in enhanced endothelial regeneration and reduction in neointimal formation as compared with controls. This seems to be a promising treatment strategy for preventing in-stent restenosis (ISR) while simultaneously reducing the risk of stent thrombosis.
dc.publisherElsevier BV
dc.relation.ispartofMolecular Therapy
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/ie/
dc.subjectnitric-oxide synthase
dc.subjectsmooth-muscle-cells
dc.subjectcarotid arteries
dc.subjectin-vivo
dc.subjectcoronary-arteries
dc.subjectno synthase
dc.subjectproliferation
dc.subjectexpression
dc.subjectatherosclerosis
dc.subjectimplantation
dc.titleGene-eluting stents: adenovirus-mediated delivery of enos to the blood vessel wall accelerates re-endothelialization and inhibits restenosis
dc.typeArticle
dc.identifier.doi10.1038/mt.2008.165
dc.local.publishedsourcehttps://doi.org/10.1038/mt.2008.165
nui.item.downloads0


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland